A combination of ticagrelor and aspirin improved the saphenous vein graft (SVG) patency rate 12 months after coronary artery bypass grafting (CABG) compared with aspirin alone, according to results of the DACAB* trial from China.
The incidence of cardiovascular events in the first year following a primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) is comparable between patients given prasugrel and ticagrelor post-surgery, according to results of the PRAGUE-18* trial presented at AHA 2017.
The incidence of clinically significant hematoma is similar in individuals with atrial fibrillation undergoing pacemaker or defibrillator surgery regardless of whether their direct oral anticoagulants (DOACs) are continued or interrupted perioperatively, results of the BRUISE CONTROL-2* trial show.
Gastric bypass may be an effective method of reducing blood pressure (BP) levels in obese patients with hypertension, according to findings of the GATEWAY* trial presented at the AHA** 2017 Scientific Sessions.
Survival outcomes of women diagnosed with breast cancer during pregnancy are similar to that of non-pregnant women, according to a presentation at ESMO Asia 2017. However, it is important to identify the dos and don’ts when diagnosing and treating breast cancer in this population.